| 1 | skip to content ampac | | | | | | | 1 | 0.28% |
| 2 | for clinical and research | | | | | | | 1 | 0.28% |
| 3 | ampac® is designed for | | | | | | | 1 | 0.28% |
| 4 | the ampac® is designed | | | | | | | 1 | 0.28% |
| 5 | population the ampac® is | | | | | | | 1 | 0.28% |
| 6 | intended population the ampac® | | | | | | | 1 | 0.28% |
| 7 | ampac® intended population the | | | | | | | 1 | 0.28% |
| 8 | applications ampac® intended population | | | | | | | 1 | 0.28% |
| 9 | appropriate for clinical and | | | | | | | 1 | 0.28% |
| 10 | functional outcomes over an | | | | | | | 1 | 0.28% |
| 11 | psychometrically appropriate for clinical | | | | | | | 1 | 0.28% |
| 12 | yet psychometrically appropriate for | | | | | | | 1 | 0.28% |
| 13 | practical yet psychometrically appropriate | | | | | | | 1 | 0.28% |
| 14 | been shown to be | | | | | | | 1 | 0.28% |
| 15 | has been shown to | | | | | | | 1 | 0.28% |
| 16 | and has been shown | | | | | | | 1 | 0.28% |
| 17 | examining functional outcomes over | | | | | | | 1 | 0.28% |
| 18 | outcomes over an episode | | | | | | | 1 | 0.28% |
| 19 | proxy report and has | | | | | | | 1 | 0.28% |
| 20 | institutional and communitybased care | | | | | | | 1 | 0.28% |
| 21 | for use with post | | | | | | | 1 | 0.28% |
| 22 | validated for use with | | | | | | | 1 | 0.28% |
| 23 | is validated for use | | | | | | | 1 | 0.28% |
| 24 | ampac is validated for | | | | | | | 1 | 0.28% |
| 25 | the ampac is validated | | | | | | | 1 | 0.28% |
| 26 | and communitybased care settings | | | | | | | 1 | 0.28% |
| 27 | across institutional and communitybased | | | | | | | 1 | 0.28% |
| 28 | over an episode of | | | | | | | 1 | 0.28% |
| 29 | move across institutional and | | | | | | | 1 | 0.28% |
| 30 | patients move across institutional | | | | | | | 1 | 0.28% |
| 31 | post acute care as | | | | | | | 1 | 0.28% |
| 32 | of post acute care | | | | | | | 1 | 0.28% |
| 33 | episode of post acute | | | | | | | 1 | 0.28% |
| 34 | an episode of post | | | | | | | 1 | 0.28% |
| 35 | report and has been | | | | | | | 1 | 0.28% |
| 36 | or proxy report and | | | | | | | 1 | 0.28% |
| 37 | with post acute care | | | | | | | 1 | 0.28% |
| 38 | measure of a patient’s | | | | | | | 1 | 0.28% |
| 39 | across an entire episode | | | | | | | 1 | 0.28% |
| 40 | used across an entire | | | | | | | 1 | 0.28% |